Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Back
Association details:
Biomarker:
No biomarker
Cancer:
Pancreatic Cancer
Drug:
sunitinib
(
c-KIT inhibitor
,
VEGFR inhibitor
,
PDGFR inhibitor
)
Direction:
Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
Source:
NCCN
Published date:
05/23/2022
Excerpt:
Pancreatic Neuroendocrine Tumors (Well-Differentiated Grade 1/2)...Preferred Regimens...Sunitinib
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login